Thursday, April 04, 2013

SC Novartis judgment is pro-innovation


In this article in today's Indian Express, I argue that the recent Supreme Court judgment in the Novartis' case is very much pro-innovation, but tries to weed out marketing gimmicks from patent protection.
This blog has previously dealt with the issue here

No comments: